Denfac Personalized Implant Project Wins Gold Award at "SDIC Fortune Cup"Issuing time:2026-03-27 15:39
DentalGoodNews | On March 21, 2026, the award ceremony for the inaugural 2025 "SDIC Futen Cup" Yangtze River Delta Clinical Innovation and Entrepreneurship Competition was held during the second Shanghai Clinical Translation Ecosystem Forum themed "Clinical Translation, Financial Empowerment". The project "Research, Development and Application of Personalized Dental Implant Medical Products", jointly submitted by Gaofeng Medical Equipment (Wuxi)Co.,Ltd and the Ninth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine, won the Gold Award in the Medical Device category at this innovation and entrepreneurship competition. This project focuses on integrating clinical personalized needs with industrial precision manufacturing capabilities based on individual patient anatomical differences. This award signifies that this collaborative hospital-enterprise R&D pathway has gained recognition from the Shanghai clinical translation system, and the translation process for related products is expected to accelerate. It is reported that this competition was guided by the Shanghai Shenkang Hospital Development Center and Shanghai State-owned Capital Investment Co., Ltd., and jointly organized by the Shanghai Clinical Innovation and Translation Institute (SCITI), Shanghai Futen Private Equity Fund Management Co., Ltd., and Bank of Shanghai Co., Ltd. It attracted participation from over 20 municipal and district-level hospitals in Shanghai, with 51 projects winning awards (20 Gold Awards, 31 Silver Awards), covering fields such as medical devices, digital healthcare, biomedicine, and AI-assisted diagnosis and treatment. Dental projects accounted for two of the Gold Awards. Held concurrently with the award ceremony was the signing ceremony for the second batch of SCITI intellectual property corporate operation cooperative hospitals. The project "Research, Development and Application of Personalized Dental Implant Medical Products" submitted by Denfac was also included in the list of signing projects for the second batch of SCITI's "Intellectual Property Corporate Operation" initiative. As a translation model pioneered by SCITI, the "Hospital Patent License + SCITI Cash Equity Investment" intellectual property corporate operation model has, since the implementation of its first project in 2025, cumulatively promoted 8 projects to complete company registration or initiate the registration process, with a total planned investment amount of approximately 90 million RMB. The signing of this second batch of projects marks the transition of this model from "single-point piloting" to a replicable and scalable stage. Against this backdrop, the dental implant-related project submitted by Denfac simultaneously winning the competition's Gold Award and entering the signing system indicates that innovative projects in the dental device field are gradually entering a synergistic advancement stage of "clinical demand - technology development - translation and implementation". Driven by the trends of personalization and digitalization, the hospital-enterprise cooperation model surrounding dental implants and related products is expected to become one of the important pathways for clinical innovation translation. # About Denfac The company was founded in 1992 and has been deeply engaged in the dental medical device processing field for 33 years. Located in the Huishan Life Science and Technology Industrial Park in Wuxi, it has a production base of approximately 20,000 square meters and over 200 employees. The company holds more than 110 intellectual property patents (including 17 invention patents), has obtained over 30 Class I to Class III medical device product registration certificates, was recognized as a National-level Specialized, Refined, Distinctive, and Innovative "Little Giant" enterprise in 2025, and has established cooperative relationships with nearly 300 dental laboratories nationwide.
【GOODNEWS】 Content for industry reference only (based on public info & professional judgment); not for decision-making. Readers bear full responsibility for their own judgment and risks.
Copyright © This Platform. Unauthorized reproduction & commercial use prohibited.
Errata, contributions & cooperation: Contact customer service via WeChat:HDSW_001
|
✉️
Subscribe to Our
Newsletter
We curate important stories and exclusive insights, delivered straight to your inbox.
In-depth analysis · Exclusive content · Fast-moving news
|